866-997-4948(US-Canada Toll Free)

bioMerieux S.A. (BIM) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Jun 2012

Category :

Surgical Equipment

No. of Pages : 89 Pages


bioMerieux S.A. (bioMerieux) undertakes the design, development and manufacture of diagnostic systems and reagents for physicians and biologists. It operates through two business divisions, namely, Clinical Applications and Industrial Applications. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used in diagnosing infectious diseases and provide high medical value results in cancer screening and monitoring and cardiovascular emergencies. Its products also detect microorganisms in food, pharmaceutical and cosmetic products. The company conducts its operations across the world through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy lEtoile, France.

The company seeks to capitalize on growth opportunities across its core markets and new markets. The business strategy of bioMerieux envisages building its position in the marketplace through internal development, new product launches, market expansion, partnerships, strategic alliances and acquisitions. As a part of its strategy, the company acquired AES Laboratoire and ARGENE, and it also entered into partnerships with Ipsen, Shanghai Institutes for Biological Sciences and Uppsala Clinical Research Center.

This report is a source for data, analysis and actionable intelligence on the bioMerieux S.A. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

List of Tables
List of Figures
bioMerieux S.A. - Business Description
Key Facts
bioMerieux S.A. - Major Products and Services
bioMerieux S.A. Pipeline Products by Equipment Type
bioMerieux S.A. Pipeline Products by Development Stage
bioMerieux S.A. Pipeline Products by Therapy Area
bioMerieux S.A. Pipeline Products by Trial Phase
bioMerieux S.A. Pipeline Products by Milestone Summary
Annexin A3 Prostate Cancer Marker
Annexin A3 Prostate Cancer Marker Product Status
Annexin A3 Prostate Cancer Marker Product Description
Annexin A3 Prostate Cancer Marker Product Patent Details
Apollo System - CMV Assay
Apollo System - CMV Assay Product Status
Apollo System - CMV Assay Product Description
Apollo System - CMV Assay Product Patent Details
Apollo System - Epstein-Barr Virus Assay
Apollo System - Epstein-Barr Virus Assay Product Status
Apollo System - Epstein-Barr Virus Assay Product Description
Apollo System - HSV1 Assay
Apollo System - HSV1 Assay Product Status
Apollo System - HSV1 Assay Product Description
Apollo System - HSV2 Assay
Apollo System - HSV2 Assay Product Status
Apollo System - HSV2 Assay Product Description 40
Apollo Sytem - MRSA Assay 41
Apollo Sytem - MRSA Assay Product Status 41
Apollo Sytem - MRSA Assay Product Description 41
BRAF - Breast Cancer Assay 42
BRAF - Breast Cancer Assay Product Status 42
BRAF - Breast Cancer Assay Product Description 42
BRAF - Breast Cancer Assay Product Milestone 43
BRAF Mutation Test 44
BRAF Mutation Test Product Status 44
BRAF Mutation Test Product Description 44
Companion Diagnostic Test - Hormone-Dependent Breast Cancer 45
Companion Diagnostic Test - Hormone-Dependent Breast Cancer Product Status 45
Companion Diagnostic Test - Hormone-Dependent Breast Cancer Product Description 45
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor 46
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor Product Status 46
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor Product Description 46
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor 47
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor Product Status 47
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor Product Description 47
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer 48
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer Product Status 48
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer Product Description 48
Diagnostic Assay - Melanoma 49
Diagnostic Assay - Melanoma Product Status 49
Diagnostic Assay - Melanoma Product Description 49
Diagnostic Assay - Melanoma Product Milestone 50
Diagnostic Assay - Sepsis 51
Diagnostic Assay - Sepsis Product Status 51
Diagnostic Assay - Sepsis Product Description 51
Diagnostic Test - Colorectal Cancer 52
Diagnostic Test - Colorectal Cancer Product Status 52
Diagnostic Test - Colorectal Cancer Product Description 52
Integrated VITEK Platform 53
Integrated VITEK Platform Product Status 53
Integrated VITEK Platform Product Description 53
KPC Assay 54
KPC Assay Product Status 54
KPC Assay Product Description 54
KRAS Test 55
KRAS Test Product Status 55
KRAS Test Product Description 55
NDM-1 Assay 56
NDM-1 Assay Product Status 56
NDM-1 Assay Product Description 56
New Blood Culture System 57
New Blood Culture System Product Status 57
New Blood Culture System Product Description 57
Next Generation BacT/ALERT System 58
Next Generation BacT/ALERT System Product Status 58
Next Generation BacT/ALERT System Product Description 58
Next Generation VIDAS 59
Next Generation VIDAS Product Status 59
Next Generation VIDAS Product Description 59
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test 60
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Status 60
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Description 60
NucliSENS EasyQ Legionella spp Test 61
NucliSENS EasyQ Legionella spp Test Product Status 61
NucliSENS EasyQ Legionella spp Test Product Description 61
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test 62
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Status 62
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Description 62
Point Of Care Testing Device 63
Point Of Care Testing Device Product Status 63
Point Of Care Testing Device Product Description 63
Smart Incubator 64
Smart Incubator Product Status 64
Smart Incubator Product Description 64
Tuberculosis Diagnostic Test 65
Tuberculosis Diagnostic Test Product Status 65
Tuberculosis Diagnostic Test Product Description 65
VIDAS - C. Difficile Assay 66
VIDAS - C. Difficile Assay Product Status 66
VIDAS - C. Difficile Assay Product Description 66
VIDAS - C. Difficile Assay Product Patent Details 67
VIDAS - Galectin-3 Assay 68
VIDAS - Galectin-3 Assay Product Status 68
VIDAS - Galectin-3 Assay Product Description 68
VIDAS - HCV Assay 69
VIDAS - HCV Assay Product Status 69
VIDAS - HCV Assay Product Description 69
VIDAS - hsCRP Assay 70
VIDAS - hsCRP Assay Product Status 70
VIDAS - hsCRP Assay Product Description 70
VIDAS - Troponin I Ultra Assay 71
VIDAS - Troponin I Ultra Assay Product Status 71
VIDAS - Troponin I Ultra Assay Product Description 71
VIDAS - Troponin I Ultra Assay Product Patent Details 72
VIDAS - Vitamin D Test 73
VIDAS - Vitamin D Test Product Status 73
VIDAS - Vitamin D Test Product Description 73
VRE Assay 74
VRE Assay Product Status 74
VRE Assay Product Description 74
VRE Assay Product Patent Details 74
bioMerieux S.A. - Key Competitors 77
bioMerieux S.A. - Key Employees 78
bioMerieux S.A. - Key Employee Biographies 79
bioMerieux S.A. - Locations And Subsidiaries 80
Head Office 80
Other Locations & Subsidiaries 80
Recent Developments 83
bioMerieux S.A., Recent Developments 83
Nov 18, 2011: bioMérieux Initiative To Support European Antibiotic Awareness Day
Oct 20, 2011: bioMerieux Reports Revenues Of €347.3m In Q3 2011
Sep 06, 2011: bioMerieux Reports Net Sales Of €673.4m In H1 2011
Jun 30, 2011: Global Call For Action To Fight Antibiotic Resistance Discussed At Fondation Mérieux’s Conference Center For Third Edition Of World HAI Forum
May 05, 2011: bioMérieux And Labor Berlin To Establish Center Of Excellence In Laboratory Diagnostics
Apr 21, 2011: bioMerieux Reports Revenues Of €327.6m In Q1 2011
Mar 08, 2011: bioMerieux Reports Net Sales Of €1.3 Billion In 2010
Jan 04, 2011: bioMerieux Appoints James Whelan As Executive Vice President, Commercial Services

Appendix
Methodology
About GlobalData
Contact Us
Disclaimer  

List of Table


bioMerieux S.A., Key Facts 1
bioMerieux S.A. Key Pipeline Products by Equipment Type 1
bioMerieux S.A. Key Pipeline Products by Therapy Area 1
bioMerieux S.A. Key Pipeline Products by Development Stage 1
bioMerieux S.A. Key Pipeline Products by Trial Phase 1
bioMerieux S.A., Key Facts 9
bioMerieux S.A., Major Products and Services 10
bioMerieux S.A. Number of Pipeline Products by Equipment Type 12
bioMerieux S.A. Pipeline Products by Equipment Type 13
bioMerieux S.A. Number of Pipeline Products by Development Stage 15
bioMerieux S.A. Pipeline Products by Development Stage 16
bioMerieux S.A. Number of Pipeline Products by Therapy Area 18
bioMerieux S.A. Pipeline Products by Therapy Area 19
bioMerieux S.A. Number of Pipeline Products by Trial Phase 21
bioMerieux S.A. Pipeline Products by Trial Phase 21
bioMerieux S.A. Number of Pipeline Products By Milestone Summary 22
bioMerieux S.A. Pipeline Products by Milestone Summary 22
Annexin A3 Prostate Cancer Marker - Product Status 23
Annexin A3 Prostate Cancer Marker - Product Description 23
Annexin A3 Prostate Cancer Marker - Patent Details 23
Apollo System - CMV Assay - Product Status 36
Apollo System - CMV Assay - Product Description 36
Apollo System - CMV Assay - Patent Details 36
Apollo System - Epstein-Barr Virus Assay - Product Status 38
Apollo System - Epstein-Barr Virus Assay - Product Description 38
Apollo System - HSV1 Assay - Product Status 39
Apollo System - HSV1 Assay - Product Description 39
Apollo System - HSV2 Assay - Product Status 40
Apollo System - HSV2 Assay - Product Description 40
Apollo Sytem - MRSA Assay - Product Status 41
Apollo Sytem - MRSA Assay - Product Description 41
BRAF - Breast Cancer Assay - Product Status 42
BRAF - Breast Cancer Assay - Product Description 42
BRAF - Breast Cancer Assay - Product Milestone 43
BRAF Mutation Test - Product Status 44
BRAF Mutation Test - Product Description 44
Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status 45
Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description 45
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Status 46
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Description 46
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Status 47
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Description 47
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status 48
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description 48
Diagnostic Assay - Melanoma - Product Status 49
Diagnostic Assay - Melanoma - Product Description 49
Diagnostic Assay - Melanoma - Product Milestone 50
Diagnostic Assay - Sepsis - Product Status 51
Diagnostic Assay - Sepsis - Product Description 51
Diagnostic Test - Colorectal Cancer - Product Status 52
Diagnostic Test - Colorectal Cancer - Product Description 52
Integrated VITEK Platform - Product Status 53
Integrated VITEK Platform - Product Description 53
KPC Assay - Product Status 54
KPC Assay - Product Description 54
KRAS Test - Product Status 55
KRAS Test - Product Description 55
NDM-1 Assay - Product Status 56
NDM-1 Assay - Product Description 56
New Blood Culture System - Product Status 57
New Blood Culture System - Product Description 57
Next Generation BacT/ALERT System - Product Status 58
Next Generation BacT/ALERT System - Product Description 58
Next Generation VIDAS - Product Status 59
Next Generation VIDAS - Product Description 59
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Status 60
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Description 60
NucliSENS EasyQ Legionella spp Test - Product Status 61
NucliSENS EasyQ Legionella spp Test - Product Description 61
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Status 62
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Description 62
Point Of Care Testing Device - Product Status 63
Point Of Care Testing Device - Product Description 63
Smart Incubator - Product Status 64
Smart Incubator - Product Description 64
Tuberculosis Diagnostic Test - Product Status 65
Tuberculosis Diagnostic Test - Product Description 65
VIDAS - C. Difficile Assay - Product Status 66
VIDAS - C. Difficile Assay - Product Description 66
VIDAS - C. Difficile Assay - Patent Details 67
VIDAS - Galectin-3 Assay - Product Status 68
VIDAS - Galectin-3 Assay - Product Description 68
VIDAS - HCV Assay - Product Status 69
VIDAS - HCV Assay - Product Description 69
VIDAS - hsCRP Assay - Product Status 70
VIDAS - hsCRP Assay - Product Description 70
VIDAS - Troponin I Ultra Assay - Product Status 71
VIDAS - Troponin I Ultra Assay - Product Description 71
VIDAS - Troponin I Ultra Assay - Patent Details 72
VIDAS - Vitamin D Test - Product Status 73
VIDAS - Vitamin D Test - Product Description 73
VRE Assay - Product Status 74
VRE Assay - Product Description 74
VRE Assay - Patent Details 74
bioMerieux S.A., Key Employees 78
bioMerieux S.A., Key Employee Biographies 79
bioMerieux S.A., Other Locations 80
bioMerieux S.A., Subsidiaries 80

List of Chart


bioMerieux S.A. Key Pipeline Products by Equipment Type 1
bioMerieux S.A. Pipeline Products by Equipment Type 12
bioMerieux S.A. Pipeline Products by Development Stage 15
bioMerieux S.A. Pipeline Products by Therapy Area 18
bioMerieux S.A. Pipeline Products by Trial Phase 21
bioMerieux S.A. Pipeline Products by Milestone Summary 22

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *